# Heparin Sodium

NDC: 63323-118
Generic name: Heparin Sodium
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20181116

FDA application: NDA017029

## Active ingredients

- HEPARIN SODIUM: 5000 [USP'U]/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-118"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-118
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9207cef5-4cec-41e7-a351-29ba726feb44